Heart in Diabetes
Heart in Diabetes
July 14, 2019
1 min watch
Save

VIDEO: SGLT-2 inhibitors provide positive cardiorenal outcomes

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

PHILADELPHIA — In this video exclusive, Mark E. Cooper, AO, PhD, head of the department of diabetes at Monash University in Melbourne, Australia, outlines some of the highlights of his presentation at Heart in Diabetes, which focused on how the kidney and heart interact to affect cardiovascular health for patients with diabetes.

Cooper discusses tools that can be used to treat patients with both kidney disease and CVD who also have diabetes, including SGLT-2 inhibitors, which may lead to superior glycemic management and reduced instances of failure of the kidneys and the heart.

Watch the video for more.